ClearBridge Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.31M Sell
112,334
-780
-0.7% -$40.1K ﹤0.01% 565
2026
Q1
$6.7M Sell
113,114
-3,376
-3% -$219K 0.01% 525
2025
Q4
$7.19M Sell
116,490
-10,220
-8% -$626K 0.01% 536
2025
Q3
$7.91M Buy
126,710
+27,017
+27% +$1.88M 0.01% 541
2025
Q2
$7.96M Sell
99,693
-62,509
-39% -$5.23M 0.01% 515
2025
Q1
$13.9M Sell
162,202
-76,779
-32% -$6.3M 0.01% 449
2024
Q4
$18.7M Sell
238,981
-201
-0.1% -$15.6K 0.02% 449
2024
Q3
$17.2M Sell
239,182
-1,847
-0.8% -$131K 0.01% 468
2024
Q2
$16.6M Sell
241,029
-4,926
-2% -$334K 0.01% 475
2024
Q1
$17.8M Sell
245,955
-33,962
-12% -$2.27M 0.01% 474
2023
Q4
$17.1M Buy
279,917
+1,621
+0.6% +$96.3K 0.01% 485
2023
Q3
$15.9M Sell
278,296
-7,929
-3% -$479K 0.02% 457
2023
Q2
$17M Buy
286,225
+34,378
+14% +$2.06M 0.02% 460
2023
Q1
$15.8M Buy
+251,847
New +$15.7M 0.02% 464

Other funds holding PBH

ClearBridge Investments's PBH Position: Q2 2026 in Review

ClearBridge Investments reduced its Prestige Consumer Healthcare (PBH) stake by 0.69% in Q2 2026, selling an estimated $40.1K and leaving 112,334 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #565.

ClearBridge Investments first reported a position in PBH in Q1 2023 and has held it in 14 quarters since. The position peaked at $18.7M in Q4 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • ClearBridge Investments held 112,334 shares of Prestige Consumer Healthcare worth $5.31M as of Q2 2026.
  • ClearBridge Investments sold 780 Prestige Consumer Healthcare shares in Q2 2026, an estimated $40.1K.
  • Prestige Consumer Healthcare made up ﹤0.01% of ClearBridge Investments's portfolio in Q2 2026, its #565 holding.
  • ClearBridge Investments first reported a position in Prestige Consumer Healthcare in Q1 2023 and has held it in 14 quarters since.
  • ClearBridge Investments's Prestige Consumer Healthcare position peaked at $18.7M in Q4 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.